- Home
- ASH vs WGS Comparison
ASH vs WGS Comparison
Compare ASH & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASH
- WGS
- Stock Information
- Founded
- ASH 1924
- WGS 2017
- Country
- ASH United States
- WGS United States
- Employees
- ASH N/A
- WGS N/A
- Industry
- ASH Specialty Chemicals
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- ASH Consumer Discretionary
- WGS Technology
- Exchange
- ASH Nasdaq
- WGS Nasdaq
- Market Cap
- ASH 2.4B
- WGS 2.4B
- IPO Year
- ASH N/A
- WGS N/A
- Fundamental
- Price
- ASH $47.33
- WGS $120.00
- Analyst Decision
- ASH Buy
- WGS Strong Buy
- Analyst Count
- ASH 7
- WGS 7
- Target Price
- ASH $60.67
- WGS $102.14
- AVG Volume (30 Days)
- ASH 660.3K
- WGS 498.9K
- Earning Date
- ASH 11-05-2025
- WGS 10-28-2025
- Dividend Yield
- ASH 3.51%
- WGS N/A
- EPS Growth
- ASH N/A
- WGS N/A
- EPS
- ASH N/A
- WGS 0.05
- Revenue
- ASH $1,869,000,000.00
- WGS $362,321,000.00
- Revenue This Year
- ASH N/A
- WGS $36.01
- Revenue Next Year
- ASH $2.82
- WGS $19.01
- P/E Ratio
- ASH N/A
- WGS $2,495.92
- Revenue Growth
- ASH N/A
- WGS 48.70
- 52 Week Low
- ASH $45.21
- WGS $48.95
- 52 Week High
- ASH $88.89
- WGS $136.00
- Technical
- Relative Strength Index (RSI)
- ASH 34.36
- WGS 52.59
- Support Level
- ASH $46.30
- WGS $104.49
- Resistance Level
- ASH $49.27
- WGS $123.51
- Average True Range (ATR)
- ASH 1.28
- WGS 6.14
- MACD
- ASH -0.08
- WGS -0.83
- Stochastic Oscillator
- ASH 19.63
- WGS 58.79
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.